HomeACMESOLAR › Filing
🔔 Get instant alerts when ACMESOLAR files quarterly results on BSE Start free trial →

Investor Presentation of ACME Solar Holdings Limited

Filed: 29 Jul 2026, 20:44 IST Exchange: BSE Category: Financial Results — Audited Results
Q1FY27 results (unaudited): Standalone: Revenue 9.54bn +63.3% y-y (5.84bn) EBITDA 8.31bn +56.5% y-y (5.31bn) EBITDA margin 87.1% (91.0%) -390 bps y-y PAT 2.35bn +79.9% y-y (1.31bn) Consolidated: Revenue 23.58bn +547.8% y-y (3.64bn) EBITDA 2.62bn +330.0% y-y (0.61bn) EBITDA margin 11.1% (16.8%) -570 bps y-y PAT 1.22bn +12100% y-y (0.01bn) Dividend: Not stated Commentary: Highest ever quarterly revenue and EBITDA achieved for the quarter; highest ever quarterly CUF at 30.9%.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 ACMESOLAR — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add ACMESOLAR to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Acme Solar Holdings Limited

Important. The summary above is generated automatically from Acme Solar Holdings Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.